Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 3
1998 1
1999 4
2000 1
2001 1
2002 2
2004 1
2005 1
2006 2
2007 1
2009 1
2011 4
2012 1
2015 3
2016 2
2017 1
2018 1
2019 2
2020 2
2021 3
2022 1
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
p38β and Cancer: The Beginning of the Road.
Roche O, Fernández-Aroca DM, Arconada-Luque E, García-Flores N, Mellor LF, Ruiz-Hidalgo MJ, Sánchez-Prieto R. Roche O, et al. Among authors: ruiz hidalgo mj. Int J Mol Sci. 2020 Oct 12;21(20):7524. doi: 10.3390/ijms21207524. Int J Mol Sci. 2020. PMID: 33053909 Free PMC article. Review.
P38 MAPK and Radiotherapy: Foes or Friends?
García-Flores N, Jiménez-Suárez J, Garnés-García C, Fernández-Aroca DM, Sabater S, Andrés I, Fernández-Aramburo A, Ruiz-Hidalgo MJ, Belandia B, Sanchez-Prieto R, Cimas FJ. García-Flores N, et al. Among authors: ruiz hidalgo mj. Cancers (Basel). 2023 Jan 30;15(3):861. doi: 10.3390/cancers15030861. Cancers (Basel). 2023. PMID: 36765819 Free PMC article. Review.
ERK5 Is a Major Determinant of Chemical Sarcomagenesis: Implications in Human Pathology.
Arconada-Luque E, Jiménez-Suarez J, Pascual-Serra R, Nam-Cha SH, Moline T, Cimas FJ, Fliquete G, Ortega-Muelas M, Roche O, Fernández-Aroca DM, Muñoz Velasco R, García-Flores N, Garnés-García C, Sánchez-Fdez A, Matilla-Almazán S, Sánchez-Arévalo Lobo VJ, Hernández-Losa J, Belandia B, Pandiella A, Esparís-Ogando A, Ramón Y Cajal S, Del Peso L, Sánchez-Prieto R, Ruiz-Hidalgo MJ. Arconada-Luque E, et al. Among authors: ruiz hidalgo mj. Cancers (Basel). 2022 Jul 19;14(14):3509. doi: 10.3390/cancers14143509. Cancers (Basel). 2022. PMID: 35884568 Free PMC article.
Etiopathogenic role of ERK5 signaling in sarcoma: prognostic and therapeutic implications.
Sánchez-Fdez A, Matilla-Almazán S, Del Carmen S, Abad M, Arconada-Luque E, Jiménez-Suárez J, Chinchilla-Tábora LM, Ruíz-Hidalgo MJ, Sánchez-Prieto R, Pandiella A, Esparís-Ogando A. Sánchez-Fdez A, et al. Among authors: ruiz hidalgo mj. Exp Mol Med. 2023 Jun;55(6):1247-1257. doi: 10.1038/s12276-023-01008-x. Epub 2023 Jun 19. Exp Mol Med. 2023. PMID: 37332046 Free PMC article.
MAPK11 (p38β) is a major determinant of cellular radiosensitivity by controlling ionizing radiation-associated senescence: An in vitro study.
Fernández-Aroca DM, García-Flores N, Frost S, Jiménez-Suárez J, Rodríguez-González A, Fernández-Aroca P, Sabater S, Andrés I, Garnés-García C, Belandia B, Cimas FJ, Villar D, Ruiz-Hidalgo MJ, Sánchez-Prieto R. Fernández-Aroca DM, et al. Among authors: ruiz hidalgo mj. Clin Transl Radiat Oncol. 2023 Jun 2;41:100649. doi: 10.1016/j.ctro.2023.100649. eCollection 2023 Jul. Clin Transl Radiat Oncol. 2023. PMID: 37346275 Free PMC article.
p38β (MAPK11) mediates gemcitabine-associated radiosensitivity in sarcoma experimental models.
Pascual-Serra R, Fernández-Aroca DM, Sabater S, Roche O, Andrés I, Ortega-Muelas M, Arconada-Luque E, Garcia-Flores N, Bossi G, Belandia B, Ruiz-Hidalgo MJ, Sánchez-Prieto R. Pascual-Serra R, et al. Among authors: ruiz hidalgo mj. Radiother Oncol. 2021 Mar;156:136-144. doi: 10.1016/j.radonc.2020.12.008. Epub 2020 Dec 11. Radiother Oncol. 2021. PMID: 33310004
E1a is an exogenous in vivo tumour suppressor.
Cimas FJ, Callejas-Valera JL, García-Olmo DC, Hernández-Losa J, Melgar-Rojas P, Ruiz-Hidalgo MJ, Pascual-Serra R, Ortega-Muelas M, Roche O, Marcos P, Garcia-Gil E, Fernandez-Aroca DM, Ramón Y Cajal S, Gutkind JS, Sanchez-Prieto R. Cimas FJ, et al. Among authors: ruiz hidalgo mj. Cancer Lett. 2017 Jul 28;399:74-81. doi: 10.1016/j.canlet.2017.04.010. Epub 2017 Apr 15. Cancer Lett. 2017. PMID: 28416454
Ferrozoles: Ferrocenyl derivatives of letrozole with dual effects as potent aromatase inhibitors and cytostatic agents.
Diaz de Greñu B, Fernández-Aroca DM, Organero JA, Durá G, Jalón FA, Sánchez-Prieto R, Ruiz-Hidalgo MJ, Rodríguez AM, Santos L, Albasanz JL, Manzano BR. Diaz de Greñu B, et al. Among authors: ruiz hidalgo mj. J Biol Inorg Chem. 2023 Sep;28(6):531-547. doi: 10.1007/s00775-023-02006-0. Epub 2023 Jul 17. J Biol Inorg Chem. 2023. PMID: 37458856
ERK5 signalling pathway is a novel target of sorafenib: Implication in EGF biology.
Ortega-Muelas M, Roche O, Fernández-Aroca DM, Encinar JA, Albandea-Rodríguez D, Arconada-Luque E, Pascual-Serra R, Muñoz I, Sánchez-Pérez I, Belandia B, Ruiz-Hidalgo MJ, Sánchez-Prieto R. Ortega-Muelas M, et al. Among authors: ruiz hidalgo mj. J Cell Mol Med. 2021 Nov;25(22):10591-10603. doi: 10.1111/jcmm.16990. Epub 2021 Oct 16. J Cell Mol Med. 2021. PMID: 34655447 Free PMC article.
38 results